“Assessing the Clinical Outcomes of Voxelotor Treatment in Patients with Sickle Cell Disease”, Int J Appl Sci Biotechnol, vol. 12, no. 1, pp. 46–53, Mar. 2024, doi: 10.3126/ijasbt.v12i1.64057.